THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Genzyme plight leaves patients uneasy

Linda Rubenstein, who takes a Genzyme drug to treat Gaucher disease, said she would not have been able to have her son, Zach, (left) without the medication. Linda Rubenstein, who takes a Genzyme drug to treat Gaucher disease, said she would not have been able to have her son, Zach, (left) without the medication. (Josh Reynolds for The Boston Globe)
By Erin Ailworth and Megan Woolhouse
Globe Staff / June 18, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Ten-month-old Hannah Ostrea’s life hinges on an expensive drug made by just one company, Genzyme Corp. , based in Cambridge. (Full article: 1145 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass